Single-cell transcriptomic atlas throughout anti-BCMA CAR-T therapy in patients with multiple myeloma

INTRODUCTION: The emergence of chimeric antigen receptor (CAR)-T therapy targeting B cell maturation antigen (BCMA) has improved the prognosis of patients with multiple myeloma (MM); however, the majority of patients eventually experience relapse. METHODS: In this study, employing the latest single-...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Yuan, Zhao, Qian, Shen, Xuxing, Jin, Yuanyuan, Wang, Jing, Zhu, Jianfeng, Chen, Lijuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682082/
https://www.ncbi.nlm.nih.gov/pubmed/38035111
http://dx.doi.org/10.3389/fimmu.2023.1278749

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682082/
https://www.ncbi.nlm.nih.gov/pubmed/38035111
http://dx.doi.org/10.3389/fimmu.2023.1278749

Ejemplares similares